Treatment of Tuberculosis: Difference between revisions
From Proteopedia
Jump to navigationJump to search
No edit summary |
No edit summary |
||
| (2 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
<StructureSection load='' size=' | <StructureSection load='' size='350' side='right' scene='Journal:JBSD:11/Cv/4' caption=''> | ||
=== Drug Pyrazinamide | Target pyrazinamidase === | === Drug Pyrazinamide | Target pyrazinamidase === | ||
'''Drug resistance mechanism of PncA in ''Mycobacterium Tuberculosis''<ref>doi 10.1080/07391102.2012.759885</ref>''' | '''Drug resistance mechanism of PncA in ''Mycobacterium Tuberculosis''<ref>doi 10.1080/07391102.2012.759885</ref>''' | ||
| Line 7: | Line 7: | ||
=== Drug Triclosan | Target Enoyl-Acyl-Carrier Protein Reductase=== | === Drug Triclosan | Target Enoyl-Acyl-Carrier Protein Reductase=== | ||
[[Enoyl-Acyl-Carrier Protein Reductase]] is a target of anti-bacterial drugs such as triclosan (TCL)<ref>PMID:19130456</ref>. These drugs are used against tuberculosis infection. <scene name='43/434541/Cv/10'>Enoyl-Acyl-Carrier Protein Reductase is a tetramer</scene> (PDB code [[3fne]]). InhA ENR <scene name='43/434541/Cv/11'>active site contains NAD and triclosan derivative</scene>. | [[Enoyl-Acyl-Carrier Protein Reductase]] is a target of anti-bacterial drugs such as triclosan (TCL)<ref>PMID:19130456</ref>. These drugs are used against tuberculosis infection. <scene name='43/434541/Cv/10'>Enoyl-Acyl-Carrier Protein Reductase is a tetramer</scene> (PDB code [[3fne]]). InhA ENR <scene name='43/434541/Cv/11'>active site contains NAD and triclosan derivative</scene>. | ||
=== Drug [[Bedaquiline]] | Target proton pump for ATP synthase of mycobacteria === | |||
=== Drug [[Ethambutol]] | Target Mycobacterium tuberculosis arabinosyltransferase === | |||
</StructureSection> | </StructureSection> | ||
== References == | == References == | ||
<references/> | <references/> | ||
[[Category: Topic Page]] | [[Category: Topic Page]] | ||
